Doctors have long known that sleep is essential for good health, but for millions of people, sleep is not as simple as it should be.
One common problem is obstructive sleep apnea, a condition where breathing stops and starts many times during sleep.
This happens because the airway becomes blocked. People with this condition may snore loudly, wake up often during the night, and feel very tired during the day.
Sleep apnea is not just about poor sleep. It is a serious health condition. Over time, it can increase the risk of heart disease, stroke, and other problems related to the heart and blood vessels. In the United States alone, it is estimated that about 25 million people are affected.
The most common treatment for sleep apnea is a device called CPAP, which stands for continuous positive airway pressure. This device uses a mask to deliver steady air pressure into the airway, helping keep it open during sleep. Many doctors consider CPAP the best treatment for improving breathing at night.
However, there has been a puzzle in medical research.
Even though CPAP clearly improves breathing and sleep quality, large studies have not always shown that it reduces the risk of heart disease. This has left doctors wondering why the results are not the same for every patient.
Now, researchers from Mount Sinai have developed a new tool that may help answer this question. Their study, published in Communications Medicine, used machine learning, a type of artificial intelligence, to better understand how CPAP affects different people.
Instead of treating all patients the same way, the researchers wanted to predict how each individual might respond to CPAP. They used data from a large international study called the SAVE trial, which included more than 2,600 patients from many countries. This trial collected detailed information about patients’ health, sleep patterns, and medical history.
The research team looked at over 100 different factors, such as smoking habits, past illnesses, and sleep measurements. From this, they identified key features that could help predict outcomes. The machine learning model then estimated whether CPAP would reduce or increase a person’s risk of heart problems.
The results were surprising. The study found that patients did not respond to CPAP in the same way. Some people clearly benefited from the treatment. In this group, those who used CPAP had a much lower risk of future heart problems compared to similar patients who did not use the device.
At the same time, another group of patients appeared to have worse outcomes when using CPAP. These individuals had a higher risk of events such as heart attacks and strokes compared to those who did not receive the treatment.
This shows that CPAP is not a simple one-size-fits-all solution. Instead, its effects depend on the individual. This is where the new tool becomes important. By using patient data, it may help doctors decide who is most likely to benefit from CPAP and who may need a different approach.
The study also highlights a larger change in medicine. In the past, treatments were often based on what works best for the average patient. Now, there is a growing focus on personalized care. This means tailoring treatments to each person’s unique health profile.
The researchers believe that tools like this could support doctors in making better decisions. Instead of guessing, they could use data to guide treatment choices. However, the team also warns that more testing is needed before this tool can be widely used in hospitals.
There are also important limits to consider. Machine learning models depend on the quality of the data used to train them. They need to be tested in different populations to make sure they work well for everyone. In addition, even if the model predicts risk, doctors still need to use their judgment when making final decisions.
Overall, this study offers a new way of thinking about sleep apnea treatment. It suggests that the future of medicine may not be about finding one perfect treatment, but about finding the right treatment for each individual.
The research was published in Communications Medicine and represents a step toward more personalized and precise healthcare.
